Industrial companies face a challenging environment that is forcing senior executives to optimize their cost base, re-examine their business models, build new capabilities and manage in a market that is increasingly impacted by new technologies. To respond, they must build new capabilities, revamp existing sales strategies, adopt new technologies, improve competitive intelligence, develop more responsive organizational structures, and find ways to expand into new markets.
Countries around the world are facing common challenges to their healthcare systems: aging populations, increase in chronic disease, costs outpacing economic growth, consumer access to information, and technological innovation. Healthcare systems, payers, providers, solutions organizations, distributors, and healthcare investors are all pursuing improved performance through new market opportunities, improved agility, higher quality outcomes at lower costs and increasing profitability.
Consumer-facing businesses contend with a complex array of challenges and disruptive market forces. Retailers see increasing ecommerce penetration. The changing channel landscape is forcing consumer brands to restructure their go-to-market strategies. Media and entertainment companies need better ways to engage with today’s digital consumer. And travel and transport companies must keep pace with customers’ evolving purchase behavior. In short, achieving growth and profitability is harder than ever.
Industrial companies continue to play a critical role in the economic development across all major regions. Yet, executives face difficult challenges marked by slow manufacturing growth, the effects of disruptive technologies, and the power of the digital economy, all of which are transforming many sectors and causing companies to rethink their traditional business models. New competitors and participants present a number of opportunities and challenges, but both will require agile strategic responses.
Life Sciences & Pharma
The convergence of breakthrough innovations, digital advancements and new business models is opening up new opportunities for players across the life sciences sector. This increasingly competitive landscape also raises new challenges, including increased pricing pressure, uncertain market access dynamics, evolving consumer behavior and disruption from non-traditional players. These trends are forcing life sciences companies to think strategically about which avenues of growth to explore.
Private equity firms around the world rely on L.E.K. Consulting to provide them with the insights they need to make investments, grow their portfolio companies and generate superior returns on exit. Our private equity work draws on our expertise in business strategy consulting, performance improvement advice, global reach and deep industry knowledge. We work alongside our private equity clients to provide comprehensive support across the full transaction cycle.